As the FDA challenges, stalls, and dissuades many emerging biotech start-ups, researchers are also troubled by the dwindling number of resources for funding in North America. Until the SEC regulates equity-based crowdfunding, this will continue to be an issue, for only a select pool of investors can offer capital in exchange for a company’s shares at this point-in-time. But even with such limitations, researchers remain optimistic that once the final touches have been made to the JOBS Act, crowdfunding will liberate their financial bindings.....





Comments


Log in to comment or register here.
Subscribe

Share your small business tips with the community!
Share your small business tips with the community!
Share your small business tips with the community!
Share your small business tips with the community!